Kaplan‒Meier plotter data showed that high CENPF expression portended worse recurrence-free survival in breast cancer patients receiving neoadjuvant chemotherapy (NACT) (Fig. 2A, n = 403, log-rank P = 0.035). Here, CENPF is linked to breast carcinoma.